Genesis Healthcare, Inc.
GENN · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $24 | $38 | $32 | $54 |
| - Cash | $152 | $192 | $183 | $212 |
| + Debt | $2,787 | $2,969 | $3,566 | $3,810 |
| Enterprise Value | $2,660 | $2,815 | $3,416 | $3,652 |
| Revenue | $770 | $812 | $899 | $919 |
| % Growth | -5.1% | -9.7% | -2.2% | – |
| Gross Profit | $21 | $55 | -$31 | $395 |
| % Margin | 2.8% | 6.8% | -3.4% | 43% |
| EBITDA | $150 | $197 | $52 | $38 |
| % Margin | 19.5% | 24.3% | 5.7% | 4.1% |
| Net Income | $57 | $72 | -$32 | -$8 |
| % Margin | 7.4% | 8.8% | -3.6% | -0.8% |
| EPS Diluted | 0.33 | 0.42 | -0.28 | -0.15 |
| % Growth | -21.4% | 250% | -86.7% | – |
| Operating Cash Flow | -$50 | $23 | -$49 | $35 |
| Capital Expenditures | -$8 | -$7 | -$13 | -$14 |
| Free Cash Flow | -$58 | $16 | -$62 | $21 |